Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;33(11):2435-2440.
doi: 10.1007/s00198-022-06446-3. Epub 2022 Jun 28.

Patients not taking a previously prescribed bone active medication now prescribed medication through Ontario FLS

J E M Sale  1   2   3 , A Yang  4 , T Inrig  4 , S Gandhi  4 , V Elliot-Gibson  4 , R Sujic  4 , R Jain  5 , J Weldon  5 , D Linton  4 , E Bogoch  6   7
Affiliations

Patients not taking a previously prescribed bone active medication now prescribed medication through Ontario FLS

J E M Sale et al. Osteoporos Int. 2022 Nov.

Abstract

In an Ontario fracture liaison service (FLS), we compared medication prescription rates among patients not taking a previously prescribed bone active medication to those with no previous prescription. Prescription rates were similar between these two groups of patients. The FLS provided a secondary opportunity for patients to initiate bone active medication.

Purpose: We compared bone active medication prescription rates among patients presenting to an Ontario fracture liaison service (FLS) who reported not taking a previously prescribed bone active medication to those with no history of prescription.

Methods: Eligible patients were those screened in 39 fracture clinics between July 1, 2017, and September 15, 2019, who were not taking bone active medication at the time of screening and classified as high risk for future fracture based on CAROC or FRAX. Sociodemographic and clinical risk factor variables were assessed at screening. Bone active medication prescription rate was assessed within 6 months of screening and defined as having received a prescription for the medication from either a specialist or primary care provider. In cases where a specialist report was not available, patient self-reported data were collected. The chi-square test of independence was used to assess differences in prescription rates.

Results: Of 17,575 patients screened, eligible patients were 350 with a previous prescription and 2644 without a previous prescription. Compared with patients who reported no previous prescription, those who had a previous prescription were older, more likely to be female and to report a previous fracture, and less likely to smoke. There was no statistically significant difference between the medication prescription rate of patients with a previous prescription (73.7%) compared to patients with no previous prescription (70.7%) (p = 0.157).

Conclusion: A large jurisdiction-wide FLS approach provided a secondary opportunity to patients who were not taking a previously prescribed bone active medication to initiate that medication.

Keywords: Fracture liaison service; Fracture risk; Fragility fracture; Medication adherence; Medication initiation.

PubMed Disclaimer

References

    1. Reynolds K, Muntner P, Cheetham TC et al (2013) Primary non-adherence to bisphosphonates in an integrated healthcare setting. Osteoporos Int 24:2509–2517 - DOI
    1. Burden AM, Paterson JM, Solomon DH, Mamdani M, Juurlink DN, Cadarette SM (2012) Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada. Osteoporos Int 23:1075–82 - DOI
    1. Papaioannou A, Kennedy CC, Dolovich L, Adachi JD (2007) Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging 24(1):37–55 - DOI
    1. Papaioannou A, Leslie WD, Morin S et al (2010) 2010 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can Med Assoc J 182(17):1864–1873 - DOI
    1. Mitchell PJ, Cooper C, Fujita M et al (2019) Quality improvement initiatives in fragility fracture care and prevention. Curr Osteoporos Rep 17:510–520 - DOI

MeSH terms

Substances

LinkOut - more resources